Healthcare provider profile · identity verified

Stephen R Pallone, M.D.

Family Practice · SIOUX CITY, IA · NPI 1619186475

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	277	77
Levothyroxine Sodium	Levothyroxine Sodium	233	48
Omeprazole	Omeprazole	171	30
Amlodipine Besylate	Amlodipine Besylate	164	32
Tramadol Hcl	Tramadol Hcl	140	22
Lisinopril	Lisinopril	128	35
Jardiance	Empagliflozin	127	21
Metoprolol Succinate	Metoprolol Succinate	107	24
Losartan Potassium	Losartan Potassium	104	22
Lamotrigine	Lamotrigine	96	suppressed
Gabapentin	Gabapentin	90	22
Alendronate Sodium	Alendronate Sodium	89	23
Pantoprazole Sodium	Pantoprazole Sodium	88	20
Rosuvastatin Calcium	Rosuvastatin Calcium	87	25
Duloxetine Hcl	Duloxetine Hcl	86	12
Eliquis	Apixaban	84	16
Metformin Hcl	Metformin Hcl	83	18
Tamsulosin Hcl	Tamsulosin Hcl	78	20
Trazodone Hcl	Trazodone Hcl	73	17
Pravastatin Sodium	Pravastatin Sodium	64	14
Spironolactone	Spironolactone	64	15
Furosemide	Furosemide	61	17
Metoprolol Tartrate	Metoprolol Tartrate	61	12
Glipizide	Glipizide	59	15
Albuterol Sulfate Hfa	Albuterol Sulfate	57	24
Hydrochlorothiazide	Hydrochlorothiazide	55	15
Sertraline Hcl	Sertraline Hcl	55	13
Bupropion Xl	Bupropion Hcl	54	suppressed
Levetiracetam	Levetiracetam	53	suppressed
Baclofen	Baclofen	52	12
Naproxen	Naproxen	50	suppressed
Donepezil Hcl	Donepezil Hcl	46	suppressed
Ozempic	Semaglutide	46	suppressed
Simvastatin	Simvastatin	44	11
Irbesartan	Irbesartan	39	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Xarelto	Rivaroxaban	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Prednisone	Prednisone	32	11
Buspirone Hcl	Buspirone Hcl	31	suppressed
Estradiol	Estradiol	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Topiramate	Topiramate	30	suppressed
Carvedilol	Carvedilol	29	suppressed
Finasteride	Finasteride	28	suppressed
Tresiba Flextouch U-100	Insulin Degludec	28	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Memantine Hcl	Memantine Hcl	25	suppressed
Zonisamide	Zonisamide	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Glycopyrrolate	Glycopyrrolate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Primidone	Primidone	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Glyxambi	Empagliflozin/Linagliptin	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Cefdinir	Cefdinir	15	12
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Safetyglide Insulin Syringe	Syringe,needle,insuln,safe,1ml	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nucynta	Tapentadol Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error